- cAMPfield lands $180M to build gut disease drug<figure><div><img src="https://imgproxy.divecdn.com/4eoVQHFTAvljHZA3dtwvKrrS1WlgcrV7_wLUFGcZYWw/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMjMwMTMxMDIyXzEua…BioPharma Dive · 1mo ago↗ source
- STAT+: Do wearables actually help people with cardiovascular disease?In this edition of STAT Health Tech: A look at what researchers found about if using wearables help people with cardiovascular diseases, and more.STAT · 1mo ago↗ source
- Novo Nordisk expands in China and Czech; Cellares boosts Series D by $50MPlus more from Eisai and Siegfried. 🧱 Novo Nordisk's expansions: Novo Nordisk has invested around $380 million to expand its manufacturing facility in Bohumil, Central Bohemia, in the Czech Repu…